Cargando…

Corrigendum: Discovery of spirooxindole-derived small-molecule compounds as novel HDAC/MDM2 dual inhibitors and investigation of their anticancer activity

Detalles Bibliográficos
Autores principales:	Zhao, Qian, Xiong, Shan-Shan, Chen, Can, Zhu, Hong-Ping, Xie, Xin, Peng, Cheng, He, Gu, Han, Bo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486260/ https://www.ncbi.nlm.nih.gov/pubmed/37692855 http://dx.doi.org/10.3389/fonc.2023.1259550

Ejemplares similares

Discovery of spirooxindole-derived small-molecule compounds as novel HDAC/MDM2 dual inhibitors and investigation of their anticancer activity
por: Zhao, Qian, et al.
Publicado: (2022)

Editorial: Discovery of small molecule lead compounds: A driving force to unravel new anticancer targets and mechanisms
por: Zhang, Yan, et al.
Publicado: (2023)

Rational drug design, synthesis, and biological evaluation of novel chiral tetrahydronaphthalene-fused spirooxindole as MDM2-CDK4 dual inhibitor against glioblastoma
por: Wang, Biao, et al.
Publicado: (2020)

Substituted spirooxindole derivatives as potent anticancer agents through inhibition of phosphodiesterase 1
por: Barakat, Assem, et al.
Publicado: (2018)

Structure-based discovery of a novel small-molecule inhibitor of TEAD palmitoylation with anticancer activity
por: Gridnev, Artem, et al.
Publicado: (2022)

Small Molecules Targeting HATs, HDACs, and BRDs in Cancer Therapy
por: Wu, Donglu, et al.
Publicado: (2020)

Stereoselective Synthesis of the Di-Spirooxindole Analogs Based Oxindole and Cyclohexanone Moieties as Potential Anticancer Agents
por: Al-Majid, Abdullah Mohammed, et al.
Publicado: (2021)

Discovery of a cytochrome P450 enzyme catalyzing the formation of spirooxindole alkaloid scaffold
por: Nguyen, Tuan-Anh M., et al.
Publicado: (2023)

A One-Pot Three-Component Synthesis and Investigation of the In Vitro Mechanistic Anticancer Activity of Highly Functionalized Spirooxindole-Pyrrolidine Heterocyclic Hybrids
por: Kumar, Raju Suresh, et al.
Publicado: (2020)

Optimized spirooxindole-pyrazole hybrids targeting the p53-MDM2 interplay induce apoptosis and synergize with doxorubicin in A549 cells
por: Islam, Mohammad Shahidul, et al.
Publicado: (2023)

Transition metal-catalyzed synthesis of spirooxindoles
por: Saranya, P. V., et al.
Publicado: (2021)

Synthesis of Spirooxindole-O-Naphthoquinone-Tetrazolo[1,5-a]Pyrimidine Hybrids as Potential Anticancer Agents
por: Wu, Liqiang, et al.
Publicado: (2018)

Synthesis, Characterization, and Cytotoxicity of New Spirooxindoles Engrafted Furan Structural Motif as a Potential Anticancer Agent
por: Altowyan, Mezna Saleh, et al.
Publicado: (2022)

The function of natural compounds in important anticancer mechanisms
por: Nan, Yang, et al.
Publicado: (2023)

Hybrid topoisomerase I and HDAC inhibitors as dual action anticancer agents
por: Cincinelli, Raffaella, et al.
Publicado: (2018)

Synthesis of a New Class of Spirooxindole–Benzo[b]Thiophene-Based Molecules as Acetylcholinesterase Inhibitors
por: Barakat, Assem, et al.
Publicado: (2020)

Discovery of New Catalytic Topoisomerase II Inhibitors for Anticancer Therapeutics
por: Matias-Barrios, Victor M., et al.
Publicado: (2021)

Design, Synthesis, Chemical and Biochemical Insights Into Novel Hybrid Spirooxindole-Based p53-MDM2 Inhibitors With Potential Bcl2 Signaling Attenuation
por: Aziz, Yasmine M. Abdel, et al.
Publicado: (2021)

Corrigendum: Targeting JUN, CEBPB, and HDAC3: A Novel Strategy to Overcome Drug Resistance in Hypoxic Glioblastoma
por: Gao, Yixing, et al.
Publicado: (2020)

Small molecule MMRi62 targets MDM4 for degradation and induces leukemic cell apoptosis regardless of p53 status
por: Lama, Rati, et al.
Publicado: (2022)

High-Throughput Strategies for the Discovery of Anticancer Drugs by Targeting Transcriptional Reprogramming
por: Huang, Lijun, et al.
Publicado: (2021)

Hybrid molecules of protoflavones and spirooxindole derivatives with selective cytotoxicity against triple-negative breast cancer cells
por: Girst, Gábor, et al.
Publicado: (2023)

Novel Allosteric Mechanism of Dual p53/MDM2 and p53/MDM4 Inhibition by a Small Molecule
por: Grinkevich, Vera V., et al.
Publicado: (2022)

Organocatalytic Access to Enantioenriched Spirooxindole-Based 4-Methyleneazetidines
por: Rainoldi, Giulia, et al.
Publicado: (2017)

Construction of Spirooxindole Skeleton Through Intramolecular Dieckmann Cyclization
por: Wu, Ting, et al.
Publicado: (2017)

Spirooxindole: A Versatile Biologically Active Heterocyclic Scaffold
por: Panda, Siva S., et al.
Publicado: (2023)

Clinical Overview of MDM2/X-Targeted Therapies
por: Burgess, Andrew, et al.
Publicado: (2016)

Discovery of N-(2-Amino-4-Fluorophenyl)-4-[bis-(2-Chloroethyl)-Amino]-Benzamide as a Potent HDAC3 Inhibitor
por: Chen, Yiming, et al.
Publicado: (2020)

The Aza-Prins Reaction of 1,2-Dicarbonyl Compounds with 3-Vinyltetrahydroquinolines: Application to the Synthesis of Polycyclic Spirooxindole Derivatives
por: Saito, Shinichi, et al.
Publicado: (2021)

Strategies for Discovery of Small Molecule Radiation Protectors and Radiation Mitigators
por: Greenberger, Joel S., et al.
Publicado: (2012)

Reciprocal Induction of MDM2 and MYCN in Neural and Neuroendocrine Cancers
por: Tran, Hung N., et al.
Publicado: (2020)

MDM2/X Inhibitors as Radiosensitizers for Glioblastoma Targeted Therapy
por: Miles, Xanthene, et al.
Publicado: (2021)

Targeting the MDM2-p53 pathway in dedifferentiated liposarcoma
por: Traweek, Raymond S., et al.
Publicado: (2022)

An Updated Review on Marine Anticancer Compounds: The Use of Virtual Screening for the Discovery of Small-Molecule Cancer Drugs
por: Ruiz-Torres, Verónica, et al.
Publicado: (2017)

DFT Study on the Substituent Effect of Anticancer Picoline-Diazido-Pt(IV) Compounds
por: Mu, Meilin, et al.
Publicado: (2022)

Application of In Silico Filtering and Isothermal Titration Calorimetry for the Discovery of Small Molecule Inhibitors of MDM2
por: Alali, Hen, et al.
Publicado: (2022)

Expanding the chemical diversity of spirooxindoles via alkylative pyridine dearomatization
por: Dai, Chunhui, et al.
Publicado: (2012)

Titanium(IV)-Catalyzed Stereoselective Synthesis of Spirooxindole-1-pyrrolines
por: Badillo, Joseph J., et al.
Publicado: (2014)

Structural basis of the stereoselective formation of the spirooxindole ring in the biosynthesis of citrinadins
por: Liu, Zhiwen, et al.
Publicado: (2021)

TRIM31: A molecule with a dual role in cancer
por: Guo, Yafei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4togbmvgult96jn31u939cs0gt